Find here all our blog posts tagged with: pharmacovigilance.

Rows of glass vials fading from sharp focus into blur under a single overhead light, evoking uneven scrutiny across a safety monitoring system.

The Evidence Gap PV Automation Never Has to Close

FDA's mounting scrutiny of AI medical devices reveals evidence gaps even for cleared products, while pharmacovigilance AI faces no such test at all.

A clinician walks through a glass hospital corridor illuminated by abstract flowing light patterns, symbolizing AI governance built inside care settings.

The Governance Gap Belongs to the Deployer, Not the Regulator

Hospitals and pharma functions adopting generative AI now carry governance obligations that device and drug frameworks were never built to cover.

Abstract visualization of data nodes split between localized and centralized routing paths across a translucent regional boundary.

The Architecture Decision Pharmacovigilance AI Cannot Defer

Cross-jurisdictional data rules are forcing pharma safety teams to choose between centralized and localized AI architectures before regulators force the choice for them.